✦ LIBER ✦

Phosphodiesterase inhibitors. Part 2: Design, synthesis, and structure–activity relationships of dual PDE3/4-inhibitory pyrazolo[1,5-a]pyridines with anti-inflammatory and bronchodilatory activity

✍ Scribed by Koji Ochiai; Naoki Ando; Kazuhiko Iwase; Tetsuya Kishi; Kazunori Fukuchi; Akira Ohinata; Hitomi Zushi; Tokutaro Yasue; David R. Adams; Yasushi Kohno

Book ID: 113495927
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 298 KB
Volume: 21
Category: Article
ISSN: 0960-894X
DOI: 10.1016/j.bmcl.2011.06.118

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phosphodiesterase inhibitors. Part 3: De

Phosphodiesterase inhibitors. Part 3: Design, synthesis and structure–activity relationships of dual PDE3/4-inhibitory fused bicyclic heteroaromatic-dihydropyridazinones with anti-inflammatory and bronchodilatory activity

✍ Koji Ochiai; Satoshi Takita; Tomohiko Eiraku; Akihiko Kojima; Kazuhiko Iwase; Te 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 734 KB

Phosphodiesterase inhibitors. Part 4: De

Phosphodiesterase inhibitors. Part 4: Design, synthesis and structure-activity relationships of dual PDE3/4-inhibitory fused bicyclic heteroaromatic-4,4-dimethylpyrazolones

✍ Ochiai, Koji; Takita, Satoshi; Kojima, Akihiko; Eiraku, Tomohiko; Ando, Naoki; I 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 712 KB

Design, Synthesis, and Biological Evalua

Design, Synthesis, and Biological Evaluation of 3-[4-(2-Hydroxyethyl)piperazin-1-yl]-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido[3,4-b]pyrazin-2(1H)-one, a Potent, Orally Active, Brain Penetrant Inhibitor of Phosphodiesterase 5 (PDE5)

✍ Hughes, Robert O.; Rogier, D. Joseph; Jacobsen, E. Jon; Walker, John K.; MacInne 📂 Article 📅 2010 🏛 American Chemical Society 🌐 English ⚖ 905 KB

ChemInform Abstract: Synthesis and Struc

ChemInform Abstract: Synthesis and Structure-Activity Relationships of a New Model of Arylpiperazines. Part 1. 2-((4-(o-Methoxyphenyl)piperazin-1-yl)methyl)- 1,3-dioxoperhydroimidazo(1,5-a)pyridine: A Selective 5-HT1A Receptor Agonist.

✍ M. L. LOPEZ-RODRIGUEZ; M. L. ROSADO; B. BENHAMU; M. J. MORCILLO; A. M. SANZ; L. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 34 KB 👁 2 views

Structure-Based Design of Novel 2-Amino-

Structure-Based Design of Novel 2-Amino-6-phenyl-pyrimido[5′,4′:5,6]pyrimido[1,2- a ]benzimidazol-5(6 H )-ones as Potent and Orally Active Inhibitors of Lymphocyte Specific Kinase (Lck): Synthesis, SAR, and In Vivo Anti-Inflammatory Activity

✍ Martin, Matthew W.; Newcomb, John; Nunes, Joseph J.; Boucher, Christina; Chai, L 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 373 KB

Non-Nucleoside HIV-1 Reverse-Transcripta

Non-Nucleoside HIV-1 Reverse-Transcriptase Inhibitors. Part 10 : Synthesis and Anti-HIV Activity of 5-Alkyl-6-(1-naphthylmethyl)pyrimidin-4(3H)-ones with a Mono- or Disubstituted 2-Amino Function as Novel ‘Dihydro-Alkoxy-Benzyl-Oxopyrimidine’ (DABO) Analogues

✍ Yueping Wang; Fen-Er Chen; Jan Balzarini; Erik De Clercq; Christophe Pannecouque 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB 👁 2 views